31 results on '"Amadio, Patrizia"'
Search Results
2. Hemostatic system in Takotsubo patients at long-term follow-up: A hidden activation?
- Author
-
Amadio, Patrizia, Porro, Benedetta, Cavalca, Viviana, Zarà, Marta, Eligini, Sonia, Sandrini, Leonardo, Werba, José Pablo, Cosentino, Nicola, Olivares, Paolo, Galotta, Arianna, Bonomi, Alice, Tremoli, Elena, Trabattoni, Daniela, and Barbieri, Silvia Stella
- Subjects
- *
BRAIN-derived neurotrophic factor , *PLASMINOGEN activators , *PARTIAL thromboplastin time , *BLOOD hyperviscosity syndrome , *TAKOTSUBO cardiomyopathy - Abstract
Takotsubo cardiomyopathy (TTS) has long been considered a benign condition, despite recurrent events and long-term adverse outcomes are often reported. Endothelial damage, blood hyperviscosity, and platelet activation described in acute phase persist in long-term follow-up; however, TTS pathophysiology is still not fully understood. Here, we explored the hemostatic system at a median of 3.1 years after TTS to uncover additional long-lasting changes in these patients. We assessed hemostatic parameters in women with TTS (n = 23) or coronary artery disease (CAD; n = 31) and in control women (n = 26) age-matched, by thromboelastographic analysis, prothrombin time (PT) and partial thromboplastin time (aPTT) coagulation assays and microparticle exposing Tissue Factor (MP-TF). Functional fibrinogen and fibrin polymerization were analyzed by Clauss method and spectrophotometry, respectively. Platelet reactivity was evaluated by light transmission aggregometry, whereas plasminogen activator inhibitor-1 (PAI-1) and brain-derived neurotrophic factor (BDNF) were measured by ELISA kit. Compared with control subjects, TTS patients exhibit an accelerated clot formation, higher percentage of fibrin polymerization and higher PAI-1 levels. Compared with CAD, TTS patients showed sustained residual platelet activation but decreased functional fibrinogen, fibrin polymerization and MP-TF levels, prolonged aPTT and a marked BDNF increase. The long-term activation of hemostatic system observed in TTS patients compared to control subjects suggests a persistent humoral abnormality that may be related to the propensity for TTS recurrence. The higher residual platelet activity observed in TTS than in CAD patients invites investigation on TTS-tailored antiplatelet therapy potentially needed to prevent TTS adverse outcomes. • Takotsubo syndrome has been recently indicated as a life-threatening condition. • Takotsubo patients exhibit hemostatic activation compared to control subjects. • Takotsubo patients show a residual platelet activation compared to CAD patients. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
3. Effect of Clotting Duration and Temperature on BDNF Measurement in Human Serum.
- Author
-
Amadio, Patrizia, Tremoli, Elena, Barbieri, Silvia Stella, Sandrini, Leonardo, and Ieraci, Alessandro
- Subjects
- *
NEUROTROPHINS , *TISSUES , *ENDOTHELIAL cells , *LEUCOCYTES , *CARDIOVASCULAR diseases , *METABOLIC syndrome , *MEGAKARYOCYTES - Abstract
Brain-derived neurothrophic factor (BDNF) is a neurotrophin expressed in different tissues and cells, including neurons, endothelial cells, leukocytes, megakaryocytes and platelets. Modifications of BDNF in plasma and/or in serum are associated with neurodegenerative and psychiatric disorders, cardiovascular diseases, metabolic syndrome and with mortality risk. Indeed, changes in blood levels of BDNF may reflect those of its tissue of origin and/or promote pathological dysfunctions. The measurement of BDNF amount in plasma or in serum has been characterized with particular attention in the impact of different anti-coagulants, clotting duration, temperature (≲21 °C) and delay in blood sample centrifugation as well as in stability of storage. However, the influences of normothermic conditions (37 °C) and of clotting duration on BDNF levels in human serum have not been investigated yet. Here, we showed that time and temperature during serum preparation could be taken into consideration to assess the association and/or impact of BDNF levels in the occurrence of pathological conditions. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
4. Circulating Small Extracellular Vesicles Reflect the Severity of Myocardial Damage in STEMI Patients.
- Author
-
Zarà, Marta, Baggiano, Andrea, Amadio, Patrizia, Campodonico, Jeness, Gili, Sebastiano, Annoni, Andrea, De Dona, Gianluca, Carerj, Maria Ludovica, Cilia, Francesco, Formenti, Alberto, Fusini, Laura, Banfi, Cristina, Gripari, Paola, Tedesco, Calogero Claudio, Mancini, Maria Elisabetta, Chiesa, Mattia, Maragna, Riccardo, Marchetti, Francesca, Penso, Marco, and Tassetti, Luigi
- Subjects
- *
EXTRACELLULAR vesicles , *ST elevation myocardial infarction , *CARDIAC magnetic resonance imaging , *VESICLES (Cytology) , *PERCUTANEOUS coronary intervention - Abstract
Circulating small extracellular vesicles (sEVs) contribute to inflammation, coagulation and vascular injury, and have great potential as diagnostic markers of disease. The ability of sEVs to reflect myocardial damage assessed by Cardiac Magnetic Resonance (CMR) in ST-segment elevation myocardial infarction (STEMI) is unknown. To fill this gap, plasma sEVs were isolated from 42 STEMI patients treated by primary percutaneous coronary intervention (pPCI) and evaluated by CMR between days 3 and 6. Nanoparticle tracking analysis showed that sEVs were greater in patients with anterior STEMI (p = 0.0001), with the culprit lesion located in LAD (p = 0.045), and in those who underwent late revascularization (p = 0.038). A smaller sEV size was observed in patients with a low myocardial salvage index (MSI, p = 0.014). Patients with microvascular obstruction (MVO) had smaller sEVs (p < 0.002) and lower expression of the platelet marker CD41–CD61 (p = 0.039). sEV size and CD41–CD61 expression were independent predictors of MVO/MSI (OR [95% CI]: 0.93 [0.87–0.98] and 0.04 [0–0.61], respectively). In conclusion, we provide evidence that the CD41–CD61 expression in sEVs reflects the CMR-assessed ischemic damage after STEMI. This finding paves the way for the development of a new strategy for the timely identification of high-risk patients and their treatment optimization. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
5. Effect of cigarette smoke on monocyte procoagulant activity: Focus on platelet-derived brain-derived neurotrophic factor (BDNF).
- Author
-
Amadio, Patrizia, Baldassarre, Damiano, Sandrini, Leonardo, Weksler, Babette B., Tremoli, Elena, and Barbieri, Silvia S.
- Subjects
- *
BRAIN-derived neurotrophic factor , *SMOKING , *HEALTH , *MONOCYTES , *THROMBOPLASTIN , *BLOOD platelets - Abstract
Cigarette smoke (CS) activates platelets, promotes vascular dysfunction, and enhances Tissue Factor (TF) expression in blood monocytes favoring pro-thrombotic states. Brain-derived neurotrophic factor (BDNF), a member of the family of neurotrophins involved in survival, growth, and maturation of neurons, is released by activated platelets (APLTs) and plays a role in the cardiovascular system. The effect of CS on circulating levels of BDNF is controversial and the function of circulating BDNF in atherothrombosis is not fully understood. Here, we have shown that human platelets, treated with an aqueous extract of CS (CSE), released BDNF in a dose-dependent manner. In addition, incubation of human monocytes with BDNF or with the supernatant of platelets activated with CSE increased TF activity by a Tropomyosin receptor kinase B (TrkB)-dependent mechanism. Finally, comparing serum and plasma samples of 12 male never smokers (NS) and 29 male active smokers (AS) we observed a significant increase in microparticle-associated TF activity (MP-TF) as well as BDNF in AS, while in serum, BDNF behaved oppositely. Taken together these findings suggest that platelet-derived BDNF is involved in the regulation of TF activity and that CS plays a role in this pathway by favoring a pro-atherothrombotic state. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
6. Role of thromboxane-dependent platelet activation in venous thrombosis: Aspirin effects in mouse model.
- Author
-
Tarantino, Eva, Amadio, Patrizia, Squellerio, Isabella, Porro, Benedetta, Sandrini, Leonardo, Turnu, Linda, Cavalca, Viviana, Tremoli, Elena, and Barbieri, Silvia S.
- Subjects
- *
NEUTROPHILS , *THROMBOXANES , *BLOOD platelets , *VENOUS thrombosis , *ASPIRIN , *DRUG efficacy - Abstract
Recent trials suggest that Aspirin (ASA) reduces the incidence of venous thromboembolism in human. However, the molecular mechanisms underlying this effect are still unclear. In this study we assessed the effects of ASA in venous thrombosis mouse model induced by inferior vena cava (IVC) ligation and we investigated the mechanisms responsible for this effect. ASA (3 mg/kg daily for 2 days) treatment decreased the thrombus size, the amounts of tissue factor activity in plasma microvesicles (TF-MP) and the levels of 2,3-dinor Thromboxane B 2 (TXB-M) in urine compared to control mice. Interestingly, the thrombus size positively correlated with both TF-MP activity and TXB-M. In addition, positive correlation was observed between TF-MP activity and TXB-M. A reduced number of neutrophils and monocytes, and of TF-positive cells accompanied to a lower amount of fibrin and neutrophil extracellular traps (NETs) were also found in thrombi of ASA-treated mice. Similar results were obtained when mice were treated 24 h before IVC ligation with SQ29548 (1 mg/kg), a selective thromboxane receptor antagonist. In addition, transfusion of platelets in SQ29548 treated-mice excluded the likelihood of a redundant role of platelet-TP receptor in this context. Finally, incubation of macrophages and neutrophils with SQ29548 prevented TF activity and/or NETs formation induced by supernatant of activated platelets or by IBOP, a selective thromboxane analogue. In conclusion, ASA, suppressing TXA 2 , prevents macrophages and neutrophils activation and markedly reduces thrombus size with a mechanism most likely dependent of the inhibition of TF activity and NETs formation. These results provide a new link between platelet-produced thromboxane and the occurrence of venous thrombosis. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
7. Production of prostaglandin E2 induced by cigarette smoke modulates tissue factor expression and activity in endothelial cells.
- Author
-
Amadio, Patrizia, Baldassarre, Damiano, Tarantino, Eva, Zacchi, Elena, Gianellini, Sara, Squellerio, Isabella, Amato, Mauro, Weksler, Babette B., Tremoli, Elena, and Barbieri, Silvia S.
- Subjects
- *
THROMBOSIS , *PROSTANOIDS , *PROSTAGLANDIN E1 , *SIRTUINS , *CIGARETTE smoke , *ENDOTHELIAL cells - Abstract
Cigarette smoke (CS) increases the incidence of atherothrombosis, the release of prostaglandin (PG) E2, and the amount of tissue factor (TF). The link between PGE2and TF, and the impact of this interaction on CS-induced thrombosis, is unknown. Plasma from active smokers showed higher concentration of PGE2, TF total antigen, and microparticle-associated TF (MP-TF) activity compared with never smokers. Similar results were obtained in mice and in mouse cardiac endothelial cells (MCECs) after treatment with aqueous CS extracts (CSEs) plus IL-1β [CSE (6.4 puffs/L)/IL-1β (2 µg/L)]. A significant correlation between PGE2 and TF total antigen or MP-TF activity were observed in both human and mouse plasma or tissue. Inhibition of PGE synthase reduced TF in vivo and in vitro and prevented the arterial thrombosis induced by CSE/IL-1β. Only PG E receptor 1 (EP1) receptor antagonists (SC51089:IC50 ~ 1 µM, AH6809:IC50 ~ 7.5 µM) restored the normal TF and sirtuin 1 (SIRT1) levels in MCECs before PGE2 (EC50 ~ 2.5 mM) or CSE/IL-1β exposure. Similarly, SIRT1 activators (CAY10591: IC50 ~ 10 µM, resveratrol: IC50 ~ 5 µM) or prostacyclin analogs (IC50 ~ 5 µM) prevented SIRT1 inhibition and reduced TF induced by CSE/IL-1β or by PGE2. In conclusion, PGE2 increases both TF expression and activity through the regulation of the EP1/SIRT1 pathway. These findings suggest that EP1 may represent a possible target to prevent prothrombotic states. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
8. Prenylcysteine Oxidase 1 (PCYOX1), a New Player in Thrombosis.
- Author
-
Banfi, Cristina, Amadio, Patrizia, Zarà, Marta, Brioschi, Maura, Sandrini, Leonardo, and Barbieri, Silvia S.
- Subjects
- *
BLOOD platelet aggregation , *BLOOD cell count , *BLOOD cells , *THROMBIN receptors , *PLATELET-rich plasma , *THROMBOSIS , *BLOOD platelets , *EGG yolk - Abstract
Prenylcysteine Oxidase 1 (PCYOX1) is an enzyme involved in the degradation of prenylated proteins. It is expressed in different tissues including vascular and blood cells. We recently showed that the secretome from Pcyox1-silenced cells reduced platelet adhesion both to fibrinogen and endothelial cells, suggesting a potential contribution of PCYOX1 into thrombus formation. Here, we show that in vivo thrombus formation after FeCl3 injury of the carotid artery was delayed in Pcyox1−/− mice, which were also protected from collagen/epinephrine induced thromboembolism. The Pcyox1−/− mice displayed normal blood cells count, vascular procoagulant activity and plasma fibrinogen levels. Deletion of Pcyox1 reduced the platelet/leukocyte aggregates in whole blood, as well as the platelet aggregation, the alpha granules release, and the αIIbβ3 integrin activation in platelet-rich plasma, in response to adenosine diphosphate (ADP) or thrombin receptor agonist peptide (TRAP). Washed platelets from the Pcyox1−/− and WT animals showed similar phosphorylation pathway activation, adhesion ability and aggregation. The presence of Pcyox1−/− plasma impaired agonist-induced WT platelet aggregation. Our findings show that the absence of PCYOX1 results in platelet hypo-reactivity and impaired arterial thrombosis, and indicates that PCYOX1 could be a novel target for antithrombotic drugs. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
9. The α2-adrenergic receptor pathway modulating depression influences the risk of arterial thrombosis associated with BDNFVal66Met polymorphism.
- Author
-
Sandrini, Leonardo, Amadio, Patrizia, Ieraci, Alessandro, Malara, Alessandro, Werba, José P., Soprano, Paolo M., Balduini, Alessandra, Zarà, Marta, Bonomi, Alice, Veglia, Fabrizio, Colombo, Gualtiero I., Popoli, Maurizio, Lee, Francis S., Tremoli, Elena, and Barbieri, Silvia S.
- Subjects
- *
BRAIN-derived neurotrophic factor , *HYPERCOAGULATION disorders , *MYOCARDIAL infarction , *THROMBOSIS , *CORONARY artery disease , *ALPHA rhythm - Abstract
Depression is associated with thrombotic risk and arterial events, its proper management is strongly recommended in coronary artery disease (CAD) patients. We have previously shown that the Brain-Derived Neurotrophic Factor (BDNF)Val66Met polymorphism, related to depression, is associated with arterial thrombosis in mice, and with an increased risk of acute myocardial infarction in humans. Herein, expanding the previous findings on BDNFVal66Met polymorphism, we show that desipramine, a norepinephrine reuptake-inhibitor, rescues behavioral impairments, reduces the arterial thrombosis risk, abolishes pathological coagulation and platelet hyper-reactivity, normalizes leukocyte, platelet, and bone marrow megakaryocyte number and restores physiological norepinephrine levels in homozygous knock-in BDNF Val66Met (BDNFMet/Met) mice. The in vitro data confirm the enhanced procoagulant activity and the alpha 2A -adrenergic receptor (α 2A -ADR) overexpression found in BDNFMet/Met mice and we provide evidence that, in presence of Met variant, norepinephrine is crucial to up-regulate procoagulant activity and to enhance platelet generation. The α 2 -ADR antagonist rauwolscine rescues the prothrombotic phenotype in BDNFMet/Met mice and reduces procoagulant activity and platelet generation in cells transfected with BDNFMet plasmid or exposed to pro-BDNFMet peptide. Finally, we show that homozygous BDNFMet/Met CAD patients have hyper-reactive platelets overexpressing abundant α 2A -ADR. The great proplatelet release from their megakaryocytes well reflects their higher circulating platelet number compared to BDNFVal/Val patients. These data reveal an unprecedented described role of Met allele in the dysregulation of norepinephrine/α 2A -ADR pathway that may explain the predisposition to arterial thrombosis. Overall, the development of α 2A -ADR inhibitors might represent a pharmacological treatment for depression-associated thrombotic conditions in this specific subgroup of CAD patients. [Display omitted] [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
10. Cyclooxygenase-2-Derived Prostacyclin Regulates Arterial Thrombus Formation by Suppressing Tissue Factor in a Sirtuin- 1-Dependent-Manner.
- Author
-
Barbieri, Silvia S., Amadio, Patrizia, Gianellini, Sara, Tarantino, Eva, Zacchi, Elena, Veglia, Fabrizio, Howe, Louise R., Weksler, Babette B., Mussoni, Luciana, and Tremoli, Elena
- Subjects
- *
CYCLOOXYGENASE 2 , *PROSTACYCLIN , *ARTERIAL diseases , *THROMBOSIS , *KNOCKOUT mice , *COMPARATIVE studies , *SIRTUINS - Abstract
Background--Selective inhibitors of cyclooxygenase (COX)-2 increase the risk of myocardial infarction and thrombotic events, but the responsible mechanisms are not fully understood. Methods and Results--We found that ferric chloride-induced arterial thrombus formation was significantly greater in COX-2 knockout compared with wild-type mice. Cross-transfusion experiments excluded the likelihood that COX-2 knockout platelets, despite enhanced aggregation responses to collagen and thrombin, are responsible for increased arterial thrombus formation in COX-2 knockout mice. Importantly, we observed that COX-2 deletion decreased prostacyclin synthase and production and peroxisome proliferator-activated receptor- and sirtuin-1 (SIRT1) expression, with consequent increased upregulation of tissue factor (TF), the primary initiator of blood coagulation. Treatment of wild-type mice with a prostacyclin receptor antagonist or a peroxisome proliferator-activated receptor-S antagonist, which predisposes to arterial thrombosis, decreased SIRT1 expression and increased TF activity. Conversely, exogenous prostacyclin or peroxisome proliferator-activated receptor-δ agonist completely reversed the thrombotic phenotype in COX-2 knockout mice, restoring normal SIRT1 levels and reducing TF activity. Furthermore, inhibition of SIRT1 increased TF expression and activity and promoted generation of occlusive thrombi in wild-type mice, whereas SIRT1 activation was sufficient to decrease abnormal TF activity and prothrombotic status in COX-2 knockout mice Conclusions--Modulation of SIRT1 and hence TF by prostacyclin/peroxisome proliferator-activated receptor-S pathways not only represents a new mechanism in controlling arterial thrombus formation but also might be a useful target for therapeutic intervention in the atherothrombotic complications associated with COX-2 inhibitors [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
11. Tobacco smoke regulates the expression and activity of microsomal prostaglandin E synthase-1: role of prostacyclin and NADPH-oxidase.
- Author
-
Barbieri, Silvia S., Amadio, Patrizia, Gianellini, Sara, Zacchi, Elena, Weksler, Babette B., and Tremoli, Elena
- Abstract
Tobacco smoke (TS) interacts with interleukin-1β (IL-1β) to modulate generation of reactive oxygen species (ROS) and expression of cyclooxygenase-2. We explored molecular mechanisms by which TS/IL-1β alters expression and activity of microsomal-prostaglandin E synthase-1 (mPGES-1) and of prostacyclin synthase (PGIS) in mouse cardiac endothelial cells. TS (EC50 ~5 puffs/L) interacting with IL-1β (2µg/L) upregulates PGE2 production and mPGES-1 expression, reaching a plateau at 4-6 h, but down-regulates pro- stacyclin (PGI2) release by increasing IL-1β-mediated PGIS tyrosine nitration. Inhibition of NADPH-oxidase, achieved pharmacologically and/or by silencing its catalytic subunit p47phox, or exogenous PGI2 (carbaprostacyclin; IC50 ~5 µM) prevents production of both ROS and PGE2, and negativelymodulatesmPGES-1 expression induced by TS/IL-1β. Moreover, inhibiting PGI2, either using PGIS siRNA and/or CAY10441 (EC50 ~20 nM), a PGI2 receptor antagonist, increases NADPH-oxidase activation, mPGES-1 synthesis, and PGE2 production. Finally, lower PGI2 levels associated with higher PGIS tyrosine nitration, p47phox translocation to the membrane (an index of activation of NADPH-oxidase), and mPGES-1 expression and activity were detected in cardiovascular tissues of ApoE-/- mice exposed to cigarette smoke compared to control mice. In conclusion, cigarette smoke in association with cytokines alters the balance between PGI2/PGE2, reducing PGI2 production and increasing synthesis and activity of mPGES-1 via NADPH-oxidase activation, predisposing to development of pathological conditions. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
12. Potential Relation between Plasma BDNF Levels and Human Coronary Plaque Morphology.
- Author
-
Amadio, Patrizia, Cosentino, Nicola, Eligini, Sonia, Barbieri, Simone, Tedesco, Calogero Claudio, Sandrini, Leonardo, Zarà, Marta, Fabiocchi, Franco, Niccoli, Giampaolo, Magnani, Giulia, Fracassi, Francesco, Crea, Filippo, Veglia, Fabrizio, Marenzi, Giancarlo, and Barbieri, Silvia Stella
- Subjects
- *
BRAIN-derived neurotrophic factor , *CORONARY artery disease , *MYOCARDIAL infarction , *OPTICAL coherence tomography , *ATHEROSCLEROTIC plaque - Abstract
Coronary artery disease (CAD) patients are at high ischemic risk, and new biomarkers reflecting atherosclerotic disease severity and coronary plaque vulnerability are required. The Brain-Derived Neurotrophic Factor (BDNF) affects endothelial and macrophage activation suggesting its involvement in atherosclerotic plaque behavior. To investigate whether plasma BDNF is associated with in vivo coronary plaque features, assessed by optical coherence tomography (OCT), in both acute myocardial infarction (AMI) and stable angina (SA) patients, we enrolled 55 CAD patients (31 SA and 24 AMI), and 21 healthy subjects (HS). BDNF was lower in CAD patients than in HS (p < 0.0001), and it decreased with the presence, clinical acuity and severity of CAD. The greater BDNF levels were associated with OCT features of plaque vulnerability in overall CAD as well as in SA and AMI patients (p < 0.03). Specifically, in SA patients, BDNF correlated positively with macrophages' infiltration within atherosclerotic plaque (p = 0.01) and inversely with minimal lumen area (p = 0.02). In AMI patients a negative correlation between BDNF and cap thickness was found (p = 0.02). Despite a small study population, our data suggest a relationship between BDNF and coronary plaque vulnerability, showing that vulnerable plaque is positively associated with plasma BDNF levels, regardless of the clinical CAD manifestation. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
13. Persistent long-term platelet activation and endothelial perturbation in women with Takotsubo syndrome.
- Author
-
Amadio, Patrizia, Porro, Benedetta, Cavalca, Viviana, Barbieri, Silvia Stella, Eligini, Sonia, Fiorelli, Susanna, Di Minno, Alessandro, Gorini, Alessandra, Giuliani, Mattia, Werba, Josè Pablo, Cosentino, Nicola, Olivares, Paolo, Barbieri, Simone, Veglia, Fabrizio, Tremoli, Elena, and Trabattoni, Daniela
- Subjects
- *
BLOOD platelet activation , *TAKOTSUBO cardiomyopathy , *BLOOD platelet aggregation , *MYOCARDIAL infarction , *ENDOTHELIUM diseases , *SYNDROMES - Abstract
• Persistent greater amount of adrenaline was found in TTS during long-term follow-up. • TTS show endothelial perturbation with low citrulline and high thrombomodulin levels. • TTS display residual TXA 2 production even though low dose ASA treatment. • Increased TXA 2 production is paralleled by enhanced platelet aggregation. Takotsubo (TTS) syndrome is an acute cardiac condition characterized by transient and reversible left ventricle dysfunction that mainly affects postmenopausal women. Catecholamine burst is the most accredited mechanism underpinning TTS onset and leading to endothelial dysfunction and platelet activation. Even if the use of low dose acetylsalycilic acid (ASA) in this clinical setting is based on both clinical presentation and unfavorable long-term prognosis, its efficacy has been recently challenged. This study was designed to assess endothelial function, residual thromboxane formation and platelet aggregation in TTS women on low-dose ASA treatment at long-term follow-up. Twenty-eight females with previously diagnosis of TTS syndrome were enrolled. Data were compared to those obtained from 23 coronary artery disease (CAD) women with a history of acute myocardial infarction, and 26 control subjects with no TTS or clinically evident CAD. Psychological and clinical profile were assessed in all study groups at the enrollment. Main metabolites involved in L-arginine/nitric oxide pathway, urinary prostacyclin, serum and urine thromboxane metabolites were measured by LC MS/MS methods. Thrombomodulin levels were quantified using an ELISA kit, and platelet aggregation, carried out on platelet rich-plasma, was induced by ADP or by epinephrine (EPI), norepinephrine (NORE) and TRAP-6, alone or in association with ADP and evaluated by Born's method. In TTS women an endothelial derangement, characterized by reduced citrulline production and increased thrombomodulin concentration, with no perturbation in prostacyclin levels, was evidenced. In addition, despite ASA treatment, TTS displayed a higher residual thromboxane formation, in parallel with an enhanced platelet response to compared to CAD. Our study highlighted the presence of endothelial perturbation in TTS patients even at long-term from the index event. The residual thromboxane production and platelet aggregation still leave open the question about the use of low dose ASA in this clinical setting. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
14. Exosomes in Cardiovascular Diseases.
- Author
-
Zarà, Marta, Amadio, Patrizia, Campodonico, Jeness, Sandrini, Leonardo, and Barbieri, Silvia S.
- Subjects
- *
EXOSOMES , *CARDIOVASCULAR diseases , *VESICLES (Cytology) , *BODY fluids , *PARENTAL influences - Abstract
Exosomes are nano-sized biovesicles of endocytic origin physiologically released by nearly all cell types into surrounding body fluids. They carry cell-specific cargos of protein, lipids, and genetic materials and can be selectively taken up by neighboring or distant cells. Since the intrinsic properties of exosomes are strictly influenced by the state of the parental cell and by the cellular microenvironment, the analysis of exosome origin and content, and their cell-targeting specificity, make them attractive as possible diagnostic and prognostic biomarkers. While the possible role of exosomes as messengers and a regenerative tool in cardiovascular diseases (CVDs) is actively investigated, the evidence about their usefulness as biomarkers is still limited and incomplete. Further complications are due to the lack of consensus regarding the most appropriate approach for exosome isolation and characterization, both important issues for their effective clinical translation. As a consequence, in this review, we will discuss the few information currently accessible about the diagnostic/prognostic potential of exosomes in CVDs and on the methodologies available for exosome isolation, analysis, and characterization. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
15. Depression and Cardiovascular Disease: The Viewpoint of Platelets.
- Author
-
Amadio, Patrizia, Zarà, Marta, Sandrini, Leonardo, Ieraci, Alessandro, and Barbieri, Silvia Stella
- Subjects
- *
REACTIVE oxygen species , *CARDIOVASCULAR diseases , *BLOOD platelet activation , *LOW density lipoproteins , *ADIPOKINES , *BLOOD platelets - Abstract
Depression is a major cause of morbidity and low quality of life among patients with cardiovascular disease (CVD), and it is now considered as an independent risk factor for major adverse cardiovascular events. Increasing evidence indicates not only that depression worsens the prognosis of cardiac events, but also that a cross-vulnerability between the two conditions occurs. Among the several mechanisms proposed to explain this interplay, platelet activation is the more attractive, seeing platelets as potential mirror of the brain function. In this review, we dissected the mechanisms linking depression and CVD highlighting the critical role of platelet behavior during depression as trigger of cardiovascular complication. In particular, we will discuss the relationship between depression and molecules involved in the CVD (e.g., catecholamines, adipokines, lipids, reactive oxygen species, and chemokines), emphasizing their impact on platelet activation and related mechanisms. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
16. Patho- physiological role of BDNF in fibrin clotting.
- Author
-
Amadio, Patrizia, Porro, Benedetta, Sandrini, Leonardo, Fiorelli, Susanna, Bonomi, Alice, Cavalca, Viviana, Brambilla, Marta, Camera, Marina, Veglia, Fabrizio, Tremoli, Elena, and Barbieri, Silvia S.
- Abstract
Circulating levels of Brain Derived Neurotrophic Factor (BDNF) are lower in coronary heart disease (CHD) than in healthy subjects and are associated with coronary events and mortality. However, the mechanism(s) underling this association is not fully understood. We hypothesize that BDNF may influence fibrin fiber structure and clot stability, favoring clot lysis and thrombus resolution. We showed that recombinant BDNF (rh-BDNF) influenced with clot formation in a concentration-dependent manner in both purified fibrinogen and plasma from healthy subjects. In particular, rh-BDNF reduced the density of fibrin fibers, the maximum clot firmness (MCF) and the maximum clot turbidity, and affected the lysis of clot. In addition, both thrombin and reptilase clotting time were prolonged by rh-BDNF, despite the amount of thrombin formed was greater. Intriguingly, CHD patients had lower levels of BDNF, greater fibrin fibers density, higher MCF than control subjects, and a negative correlation between BDNF and MCF was found. Of note, rh-BDNF markedly modified fibrin clot profile restoring physiological clot morphology in CHD plasma. In conclusion, we provide evidence that low levels of BDNF correlate with the formation of bigger thrombi (in vitro) and that this effect is mediated, at least partially, by the alteration of fibrin fibers formation. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
17. How much does a liter of donor human milk cost? Cost analysis of operating a human milk bank in Italy.
- Author
-
Salvatori, Guglielmo, De Rose, Domenico Umberto, Clemente, Maria, Gentili, Cristina, Verardi, Giovanni Paride, Amadio, Patrizia, Reposi, Maria Paola, Bagolan, Pietro, and Dotta, Andrea
- Subjects
- *
TRANSPORTATION , *BREAST milk collection & preservation , *BREAST milk , *CROSS-sectional method , *HOSPITAL costs , *COST analysis , *WAGES - Abstract
Background: To date, 40 Human Milk Banks (HMB) have been established in Italy; however, recent cost analysis data for operating an HMB in Italy are not available in the literature. Methods: This study was a cross-sectional study performed at "Bambino Gesù" Children's Hospital in Rome, Italy in 2019. We assessed the one-year operational costs and, the per liter unit costs at our HMB. Results: During the 2019 year we collected 771 l of human milk supplied by 128 donors. The total cost was € 178,287.00 and the average cost was € 231.00 per liter. € 188,716.00 would have been spent had the maximum capacity for 904 l been reached. We found a significant difference (€ 231.00 vs € 209.00 per liter, p = 0.016) comparing the cost for collected liters in the year 2019 and the cost for the maximum capacity of the bank for that year of activity. Analyzing each cost item that determines the charge of donor human milk (DHM), the highest costs are the salaries of medical and paramedical staff, and then the costs related to transporting. If the HMB works at maximum capacity and manages a greater number of liters of milk, this can represent an important saving. Conversely, the price of consumables is modest (i.e., the price of a single-use kit for breast pumps was € 0.22 per unit). Conclusion: The costs for a liter of DHM are quite high, but they must be related to the benefits, especially for preterm infants. Comparing the cost for collected liters in 2019 and the costs for the 2019 maximum capacity of the HMB, we calculated how much fixed costs of collection and distribution of DHM can be reduced, by increasing the volume of milk collected. To the best of our knowledge, this is the first complete cost analysis for an Italian Milk Bank. A thorough analysis could help to abate fixed costs and reduce the cost of a liter of DHM. The centralization of DHM can allow savings, rather than creating small HMBs scattered throughout the territory that would operate with lower milk volumes. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
18. Participation of nurses and allied health professionals in research activities: a survey in an academic tertiary pediatric hospital.
- Author
-
Amicucci, Matteo, Dall'Oglio, Immacolata, Biagioli, Valentina, Gawronski, Orsola, Piga, Simone, Ricci, Riccardo, Angelaccio, Anna, Elia, Domenica, Fiorito, Mario E., Marotta, Luigi, Raponi, Massimiliano, Tiozzo, Emanuela, Research Study Group, Amadio, Patrizia, Brancaccio, Matilde, Campagna, Ilaria, Ciliento, Gaetano, Connola, Federica, D'Angelo, Matteo, and Lena, Davide Della
- Subjects
- *
STATISTICS , *PILOT projects , *WORK experience (Employment) , *PATIENT participation , *ACADEMIC medical centers , *SCIENTIFIC observation , *CONFIDENCE intervals , *CHILDREN'S hospitals , *CROSS-sectional method , *SELF-evaluation , *MULTIVARIATE analysis , *CLINICAL medicine research , *TERTIARY care , *FISHER exact test , *MANN Whitney U Test , *SURVEYS , *T-test (Statistics) , *NURSES , *QUESTIONNAIRES , *CHI-squared test , *PROFESSIONAL competence , *LOGISTIC regression analysis , *DATA analysis software , *ODDS ratio , *MEDICAL writing , *ALLIED health personnel - Abstract
Background: Involvement in research activities is complex in pediatric nursing and allied health professionals (AHPs). It is important to understand which individual factors are associated with it to inform policy makers in promoting research. Methods: A cross-sectional observational study was conducted to describe the level of participation in research activities over the last ten years of nurses and AHPs working in a tertiary pediatric hospital. A large sample of nurses and AHPs working in an Italian academic tertiary pediatric hospital completed an online self-report questionnaire between June and December 2018. Three multivariate logistic regression analyses were performed to predict participation in research projects, speaking at conferences, and writing scientific articles. Results: Overall, data from 921 health professionals were analyzed (response rate = 66%), of which about 21% (n = 196) reported participating in a research project, while 33% (n = 297) had attended a scientific conference as a speaker, and 11% (n = 94) had written at least one scientific paper. Having a Master or a Regional Advanced Course, working as an AHP or a ward manager, as well as regularly reading scientific journals and participation in an internal hospital research group or attendance in a specific course about research in the hospital, significantly predicted participation in research projects, speaking at conferences and writing scientific papers. It is important to foster research interest and competencies among health professionals to improve participation in research projects, speaking at conferences, and writing scientific papers. Conclusions: Overall, we found a good level of attendance at conferences as speakers (33%), a moderate level of participation in research (21%), and low levels for writing scientific papers (11%). Our study highlighted the need to support participation in research activities among nurses and AHPs. Policymakers should identify strategies to promote research among nurses and AHPs, such as protected rewarded time for research, specific education, strengthened collaboration with academics, and financial support. Moreover, hospital managers should promote the development of research culture among health professionals, to improve their research competencies and evidence-based practice. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
19. Cytokines present in smokers' serum interact with smoke components to enhance endothelial dysfunction.
- Author
-
Barbieri, Silvia S., Zacchi, Elena, Amadio, Patrizia, Gianellini, Sara, Mussoni, Luciana, Weksler, Babette B., and Tremoli, Elena
- Subjects
- *
CYTOKINES , *SMOKING , *ENDOTHELIUM , *CIGARETTE smokers , *ACTIVE oxygen in the body , *CYCLOOXYGENASES , *GENE expression - Abstract
Aims Cigarette smoking engenders inflammation and endothelial dysfunction, processes implicated in atherothrombotic disease. We hypothesized that an interaction between inflammatory cytokines in smokers' blood and circulating components of cigarette smoke is necessary to induce reactive oxygen species (ROS) and cyclooxygenase-2 (COX-2) in endothelium. We then explored the molecular mechanisms involved in these effects. Methods and results Serum from nine healthy active smokers (AS) compared with serum from nine non-smokers (NS) showed higher levels of interleukin-1beta (IL-1β) and tumour necrosis factor-alpha (TNF-α) and a greater ability to induce ROS production, p47phox translocation to the plasma membrane, and COX-2 mRNA and protein expression in endothelial cells (ECs). Similar results were obtained in vivo and in vitro after treatment with aqueous extracts of cigarette smoke plus IL-1β and TNF-α(TS/IL-1β/TNF-α). In ECs increased ROS production and COX-2 mRNA induced by serum from AS correlated positively with their serum levels of IL-1β and TNF-α. Moreover, a positive correlation was observed between ROS generation and COX-2 mRNA. Simultaneous immuno-neutralization of IL-1β and TNF-α prevented endothelial dysfunction induced by serum from AS. Inhibitors of NADPH oxidase and/or p47phox siRNA diminished ROS production and COX-2 expression as well as phosphorylation of p38 mitogen-activated protein kinase (p38MAPK) and Akt mediated either by AS serum or by TS/IL-1β/TNF-α. Finally, direct inhibition of p38MAPK and Akt activity also abolished COX-2 expression mediated by both types of stimuli. Our results suggest a crucial role played by interactions between inflammatory cytokines and tobacco smoke in the induction of endothelial dysfunction. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
20. Impact of Acute and Chronic Stress on Thrombosis in Healthy Individuals and Cardiovascular Disease Patients.
- Author
-
Sandrini, Leonardo, Ieraci, Alessandro, Amadio, Patrizia, Zarà, Marta, and Barbieri, Silvia Stella
- Subjects
- *
CARDIOVASCULAR diseases , *THROMBOSIS , *INFLAMMATION , *AUTONOMIC nervous system , *PSYCHOLOGICAL stress , *HEMATOPOIESIS - Abstract
Psychological stress induces different alterations in the organism in order to maintain homeostasis, including changes in hematopoiesis and hemostasis. In particular, stress-induced hyper activation of the autonomic nervous system and hypothalamic–pituitary–adrenal axis can trigger cellular and molecular alterations in platelets, coagulation factors, endothelial function, redox balance, and sterile inflammatory response. For this reason, mental stress is reported to enhance the risk of cardiovascular disease (CVD). However, contrasting results are often found in the literature considering differences in the response to acute or chronic stress and the health condition of the population analyzed. Since thrombosis is the most common underlying pathology of CVDs, the comprehension of the mechanisms at the basis of the association between stress and this pathology is highly valuable. The aim of this work is to give a comprehensive review of the studies focused on the role of acute and chronic stress in both healthy individuals and CVD patients, focusing on the cellular and molecular mechanisms underlying the relationship between stress and thrombosis. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
21. BDNF Val66Met polymorphism alters food intake and hypothalamic BDNF expression in mice.
- Author
-
Ieraci, Alessandro, Barbieri, Silvia S., Macchi, Chiara, Amadio, Patrizia, Sandrini, Leonardo, Magni, Paolo, Popoli, Maurizio, and Ruscica, Massimiliano
- Subjects
- *
HYPOTHALAMUS , *INGESTION , *BRAIN-derived neurotrophic factor , *WHITE adipose tissue , *ADIPOSE tissue physiology , *GLUCOSE tolerance tests , *SINGLE nucleotide polymorphisms - Abstract
Obesity, a rising public health burden, is a multifactorial disease with an increased risk for patients to develop several pathological conditions including type 2 diabetes mellitus, hypertension, and cardiovascular disease. Increasing evidence suggests a relationship between the human brain‐derived neurotrophic factor (BDNF) Val66Met single‐nucleotide polymorphism (SNP) and obesity, although the underlying mechanisms of this connection are still not completely understood. In the present study, we found that homozygous knock‐in BDNFMet/Met mice were overweight and hyperphagic compared to wildtype BDNFVal/Val mice. Increased food intake was associated with reduction of total BDNF and BDNF1, BDNF4 and BDNF6 transcripts in the hypothalamus of BDNFMet/Met mice. In contrast, in the white adipose tissue total BDNF and Glut4 expression levels were augmented, while sirtuin 1 and leptin receptor (Ob‐R) expression levels were reduced in BDNFMet/Met mice. Moreover, plasmatic leptin levels were decreased in BDNFMet/Met mice. However, BDNFVal/Val and BDNFMet/Met mice showed a similar response to the insulin tolerance test and glucose tolerance test. Altogether, these results suggest that BDNF Val66Met SNP strongly contributes to adipose tissue pathophysiology, resulting in reduced circulating leptin levels and hypothalamic expression of BDNF, which, in turn, promote increased food intake and overweight in BDNFMet/Met mice. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
22. Impact of BDNF Val66Met Polymorphism on Myocardial Infarction: Exploring the Macrophage Phenotype.
- Author
-
Sandrini, Leonardo, Castiglioni, Laura, Amadio, Patrizia, Werba, José Pablo, Eligini, Sonia, Fiorelli, Susanna, Zarà, Marta, Castiglioni, Silvia, Bellosta, Stefano, Lee, Francis S., Sironi, Luigi, Tremoli, Elena, and Barbieri, Silvia Stella
- Subjects
- *
MACROPHAGES , *MYOCARDIAL infarction , *PERITONEAL macrophages , *CARDIOVASCULAR system , *CARDIAC magnetic resonance imaging , *BRAIN-derived neurotrophic factor , *SINGLE nucleotide polymorphisms , *CARDIAC patients - Abstract
Brain-derived neurotrophic factor (BDNF) is a member of the neurotrophin growth factor family, well known for its role in the homeostasis of the cardiovascular system. Recently, the human BDNF Val66Met single nucleotide polymorphism has been associated with the increased propensity for arterial thrombosis related to acute myocardial infarction (AMI). Using cardiac magnetic resonance imaging and immunohistochemistry analyses, we showed that homozygous mice carrying the human BDNF Val66Met polymorphism (BDNFMet/Met) undergoing left anterior descending (LAD) coronary artery ligation display an adverse cardiac remodeling compared to wild-type (BDNFVal/Val). Interestingly, we observed a persistent presence of pro-inflammatory M1-like macrophages and a reduced accumulation of reparative-like phenotype macrophages (M2-like) in the infarcted heart of mutant mice. Further qPCR analyses showed that BDNFMet/Met peritoneal macrophages are more pro-inflammatory and have a higher migratory ability compared to BDNFVal/Val ones. Finally, macrophages differentiated from circulating monocytes isolated from BDNFMet/Met patients with coronary heart disease displayed the same pro-inflammatory characteristics of the murine ones. In conclusion, the BDNF Val66Met polymorphism predisposes to adverse cardiac remodeling after myocardial infarction in a mouse model and affects macrophage phenotype in both humans and mice. These results provide a new cellular mechanism by which this human BDNF genetic variant could influence cardiovascular disease. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
23. Physical Exercise Affects Adipose Tissue Profile and Prevents Arterial Thrombosis in BDNF Val66Met Mice.
- Author
-
Sandrini, Leonardo, Ieraci, Alessandro, Amadio, Patrizia, Zarà, Marta, Mitro, Nico, Lee, Francis S., Tremoli, Elena, and Barbieri, Silvia Stella
- Subjects
- *
EXERCISE , *ADIPOSE tissues , *WHITE adipose tissue , *BRAIN-derived neurotrophic factor , *THROMBOSIS , *DISEASE risk factors - Abstract
Adipose tissue accumulation is an independent and modifiable risk factor for cardiovascular disease (CVD). The recent CVD European Guidelines strongly recommend regular physical exercise (PE) as a management strategy for prevention and treatment of CVD associated with metabolic disorders and obesity. Although mutations as well as common genetic variants, including the brain-derived neurotrophic factor (BDNF) Val66Met polymorphism, are associated with increased body weight, eating and neuropsychiatric disorders, and myocardial infarction, the effect of this polymorphism on adipose tissue accumulation and regulation as well as its relation to obesity/thrombosis remains to be elucidated. Here, we showed that white adipose tissue (WAT) of humanized knock-in BDNFVal66Met (BDNFMet/Met) mice is characterized by an altered morphology and an enhanced inflammatory profile compared to wild-type BDNFVal/Val. Four weeks of voluntary PE restored the adipocyte size distribution, counteracted the inflammatory profile of adipose tissue, and prevented the prothrombotic phenotype displayed, per se, by BDNFMet/Met mice. C3H10T1/2 cells treated with the Pro-BDNFMet peptide well recapitulated the gene alterations observed in BDNFMet/Met WAT mice. In conclusion, these data indicate the strong impact of lifestyle, in particular of the beneficial effect of PE, on the management of arterial thrombosis and inflammation associated with obesity in relation to the specific BDNF Val66Met mutation. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
24. Fenretinide treatment accelerates atherosclerosis development in apoE-deficient mice in spite of beneficial metabolic effects.
- Author
-
Busnelli, Marco, Manzini, Stefano, Bonacina, Fabrizia, Soldati, Sabina, Barbieri, Silvia Stella, Amadio, Patrizia, Sandrini, Leonardo, Arnaboldi, Francesca, Donetti, Elena, Laaksonen, Reijo, Paltrinieri, Saverio, Scanziani, Eugenio, and Chiesa, Giulia
- Subjects
- *
THORACIC aorta , *SINUS of valsalva , *BODY composition , *ABDOMINAL aorta , *BLOOD lipids , *WESTERN diet , *LIPID metabolism , *ENERGY metabolism , *RETINOIDS , *BIOLOGICAL models , *DISEASE progression , *RESEARCH , *AORTIC diseases , *LIVER , *ANIMAL experimentation , *RESEARCH methodology , *ANTINEOPLASTIC agents , *BLOOD sugar , *MEDICAL cooperation , *EVALUATION research , *ATHEROSCLEROSIS , *COMPARATIVE studies , *WEIGHT loss , *RESEARCH funding , *AORTA , *SPLEEN , *LIPIDS , *MICE - Abstract
Background and Purpose: Fenretinide, a synthetic retinoid derivative first investigated for cancer prevention and treatment, has been shown to ameliorate glucose tolerance, improve plasma lipid profile and reduce body fat mass. These effects, together with its ability to inhibit ceramide synthesis, suggest that fenretinide may have an anti-atherosclerotic action.Experimental Approach: To this aim, nine-week-old apoE-knockout (EKO) female mice were fed for twelve weeks a Western diet, without (control) or with (0.1% w/w) fenretinide. As a reference, wild-type (WT) mice were treated similarly. Growth and metabolic parameters were monitored throughout the study. Atherosclerosis development was evaluated in the aorta and at the aortic sinus. Blood and lymphoid organs were further characterized with thorough cytological/histological and immunocytofluorimetric analyses.Key Results: Fenretinide treatment significantly lowered body weight, glucose levels and plasma levels of total cholesterol, triglycerides, and phospholipids. In the liver, fenretinide remarkably reduced hepatic glycogenosis and steatosis driven by the Western diet. Treated spleens were abnormally enlarged, with severe follicular atrophy and massive extramedullary haematopoiesis. Severe renal hemosiderin deposition was observed in treated EKO mice. Treatment resulted in a threefold increase of total leukocytes (WT and EKO) and raised the activated/resting monocyte ratio in EKO mice. Finally, atherosclerosis development was markedly increased at the aortic arch, thoracic and abdominal aorta of fenretinide-treated mice.Conclusions and Implications: We provide the first evidence that, despite beneficial metabolic effects, fenretinide treatment may enhance the development of atherosclerosis. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
25. Sub-Chronic Stress Exacerbates the Pro-Thrombotic Phenotype in BDNFVal/Met Mice: Gene-Environment Interaction in the Modulation of Arterial Thrombosis.
- Author
-
Sandrini, Leonardo, Ieraci, Alessandro, Amadio, Patrizia, Veglia, Fabrizio, Popoli, Maurizio, Lee, Francis S., Tremoli, Elena, and Barbieri, Silvia Stella
- Subjects
- *
THROMBOSIS , *PHENOTYPES , *LABORATORY mice , *BLOOD coagulation , *BRAIN-derived neurotrophic factor - Abstract
Brain-Derived Neurotrophic Factor (BDNF) Val66Met polymorphism has been associated with increased susceptibility to develop mood disorders and recently it has been also linked with cardiovascular disease (CVD). Interestingly, stressful conditions unveil the anxious/depressive-like behavioral phenotype in heterozygous BDNFVal66Met (BDNFVal/Met) mice, suggesting an important relationship in terms of gene-environment interaction (GxE). However, the interplay between stress and BDNFVal/Met in relation to CVD is completely unknown. Here, we showed that BDNFVal/Met mice display a greater propensity to arterial thrombosis than wild type BDNFVal/Val mice after 7 days of restraint stress (RS). RS markedly increased the number of leukocytes and platelets, and induced hyper-responsive platelets as showed by increased circulating platelet/leukocyte aggregates and enhanced expression of P-selectin and GPIIbIIIa in heterozygous mutant mice. In addition, stressed BDNFVal/Met mice had a greater number of large and reticulated platelets but comparable number and maturation profile of bone marrow megakaryocytes compared to BDNFVal/Val mice. Interestingly, RS led to a significant reduction of BDNF expression accompanied by an increased activity of tissue factor in the aorta of both BDNFVal/Val and BDNFVal/Met mice. In conclusion, we provide evidence that sub-chronic stress unveils prothrombotic phenotype in heterozygous BDNF Val66Met mice affecting both the number and functionality of blood circulating cells, and the expression of key thrombotic molecules in aorta. Human studies will be crucial to understand whether this GxE interaction need to be taken into account in risk stratification of coronary artery disease (CAD) patients. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
26. Association between Obesity and Circulating Brain-Derived Neurotrophic Factor (BDNF) Levels: Systematic Review of Literature and Meta-Analysis.
- Author
-
Sandrini, Leonardo, Di Minno, Alessandro, Amadio, Patrizia, Ieraci, Alessandro, Tremoli, Elena, and Barbieri, Silvia S.
- Subjects
- *
BRAIN-derived neurotrophic factor , *BRAIN-derived neurotrophic factor receptors , *OBESITY , *OVERWEIGHT persons , *NEUROTROPHINS - Abstract
Reduction in brain-derived neurotrophic factor (BDNF) expression in the brain as well as mutations in BDNF gene and/or of its receptor are associated to obesity in both human and animal models. However, the association between circulating levels of BDNF and obesity is still not defined. To answer this question, we performed a meta-analysis carrying out a systematic search in electronic databases. Ten studies (307 obese patients and 236 controls) were included in the analysis. Our data show that obese patients have levels of BDNF similar to those of controls (SMD: 0.01, 95% CI: −0.28, 0.30,
p = 0.94). The lack of difference was further confirmed both in studies in which BDNF levels were assessed in serum (MD: −0.93 ng/mL, 95% CI: −3.34, 1.48,p = 0.45) and in plasma (MD: 0.15 ng/mL, 95% CI: −0.09, 0.39,p = 0.23). Data evaluation has shown that some bias might affect BDNF measurements (e.g., subject recruitment, procedures of sampling, handling, and storage), leading to a difficult interpretation of the results. Standardization of the procedures is still needed to reach strong, affordable, and reliable conclusions. [ABSTRACT FROM AUTHOR]- Published
- 2018
- Full Text
- View/download PDF
27. Neonatal intensive care parent satisfaction: a multicenter study translating and validating the Italian EMPATHIC-N questionnaire.
- Author
-
Dall'Oglio, Immacolata, Fiori, Martina, Tiozzo, Emanuela, Mascolo, Rachele, Portanova, Anna, Gawronski, Orsola, Ragni, Angela, Amadio, Patrizia, Cocchieri, Antonello, Fida, Roberta, Alvaro, Rosaria, Rocco, Gennaro, and Latour, Jos M.
- Subjects
- *
STATISTICAL correlation , *FACTOR analysis , *MEDICAL cooperation , *NEONATAL intensive care , *PSYCHOMETRICS , *QUESTIONNAIRES , *RESEARCH , *SATISFACTION , *CULTURAL values , *NEONATAL intensive care units , *DISCHARGE planning , *PARENT attitudes , *RESEARCH methodology evaluation ,RESEARCH evaluation - Abstract
Background: In Neonatal Intensive Care Units (NICUs), parent satisfaction and their experiences are fundamental to assess clinical practice and improve the quality of care delivered to infants and parents. Recently, a specific instrument, the EMpowerment of PArents in THe Intensive Care-Neonatology (EMPATHIC-N), has been developed in the Netherlands. This instrument investigated different domains of care in NICUs from a family-centered care perspective. In Italy, no rigorous instruments are available to evaluate parent satisfaction and experiences in NICU with family-centered care. The aim of this study was to translate and validate the EMPATHIC-N instrument into Italian language measuring parent satisfaction. Methods: A psychometric study was conducted in nine Italian NICUs. The hospitals were allocated across Italy: four in the North, four in Central region, one in the South. Parents whose infants were discharged from the Units were enrolled. Parents whose infants died were excluded. Results: Back-forward translation was conducted. Twelve parents reviewed the instrument to assess the cultural adaptation; none of the items fell below the cut-off of 80% agreement. A total of 186 parents of infants who were discharged from nine NICUs were invited to participate and 162 parents responded and returned the questionnaire (87%). The mean scores of the individual items varied between 4.3 and 5.9. Confirmatory factor analysis was performed and all factor loadings were statistically significant with the exception of item 'Our cultural background was taken into account'. The items related to overall satisfaction showed a higher trend with mean values of 5.8 and 5.9. The Cronbach's alpha's (at domain level 0.73-0.92) and corrected item-total scale correlations revealed high reliability estimates. Conclusions: The Italian EMPATHIC-N showed to be a valid and reliable instrument measuring parent satisfaction in NICUs from a family-centered care perspective. Indeed, it had good psychometric properties, validity, and reliability. Furthermore, this instrument is fundamental for further research and internationally benchmarking. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
28. Plasma Exosome Profile in ST-Elevation Myocardial Infarction Patients with and without Out-of-Hospital Cardiac Arrest.
- Author
-
Zarà, Marta, Campodonico, Jeness, Cosentino, Nicola, Biondi, Maria Luisa, Amadio, Patrizia, Milanesi, Gloria, Assanelli, Emilio, Cerri, Silvia, Biggiogera, Marco, Sandrini, Leonardo, Tedesco, Calogero Claudio, Veglia, Fabrizio, Trabattoni, Daniela, Blandini, Fabio, Tremoli, Elena, Marenzi, Giancarlo, and Barbieri, Silvia S.
- Subjects
- *
EXOSOMES , *MYOCARDIAL infarction , *CARDIAC arrest , *CARDIOLOGICAL manifestations of general diseases , *WESTERN immunoblotting , *PATIENTS' attitudes , *PROTEIN expression - Abstract
The identification of new biomarkers allowing an early and more accurate characterization of patients with ST-segment elevation myocardial infarction (STEMI) is still needed, and exosomes represent an attractive diagnostic tool in this context. However, the characterization of their protein cargo in relation to cardiovascular clinical manifestation is still lacking. To this end, 35 STEMI patients (17 experiencing resuscitated out-of-hospital cardiac arrest (OHCA-STEMI) and 18 uncomplicated) and 32 patients with chronic coronary syndrome (CCS) were enrolled. Plasma exosomes were characterized by the nanoparticle tracking analysis and Western blotting. Exosomes from STEMI patients displayed a higher concentration and size and a greater expression of platelet (GPIIb) and vascular endothelial (VE-cadherin) markers, but a similar amount of cardiac troponin compared to CCS. In addition, a difference in exosome expression of acute-phase proteins (ceruloplasmin, transthyretin and fibronectin) between STEMI and CCS patients was found. GPIIb and brain-associated marker PLP1 accurately discriminated between OHCA and uncomplicated STEMI. In conclusion, the exosome profile of STEMI patients has peculiar features that differentiate it from that of CCS patients, reflecting the pathophysiological mechanisms involved in STEMI. Additionally, the exosome expression of brain- and platelet-specific markers might allow the identification of patients experiencing ischemic brain injury in STEMI. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
29. Biology and Role of Extracellular Vesicles (EVs) in the Pathogenesis of Thrombosis.
- Author
-
Zarà, Marta, Guidetti, Gianni Francesco, Camera, Marina, Canobbio, Ilaria, Amadio, Patrizia, Torti, Mauro, Tremoli, Elena, and Barbieri, Silvia Stella
- Subjects
- *
EXOSOMES , *THROMBOSIS , *VENOUS thrombosis , *BIOLOGY , *FREE fatty acids , *APOPTOTIC bodies - Abstract
Extracellular vesicles (EVs) are well-established mediators of cell-to-cell communication. EVs can be released by every cell type and they can be classified into three major groups according to their biogenesis, dimension, density, and predominant protein markers: exosomes, microvesicles, and apoptotic bodies. During their formation, EVs associate with specific cargo from their parental cell that can include RNAs, free fatty acids, surface receptors, and proteins. The biological function of EVs is to maintain cellular and tissue homeostasis by transferring critical biological cargos to distal or neighboring recipient cells. On the other hand, their role in intercellular communication may also contribute to the pathogenesis of several diseases, including thrombosis. More recently, their physiological and biochemical properties have suggested their use as a therapeutic tool in tissue regeneration as well as a novel option for drug delivery. In this review, we will summarize the impact of EVs released from blood and vascular cells in arterial and venous thrombosis, describing the mechanisms by which EVs affect thrombosis and their potential clinical applications. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
30. TCT-404 Takotsubo Syndrome and Oxidative Stress in Women: What Happens to the Clot.
- Author
-
Trabattoni, Daniela, Porro, Benedetta, Barbieri, Silvia, Cavalca, Viviana, Amadio, Patrizia, Eligini, Sonia, Olivares, Paolo, Fabbiocchi, Franco, Bartorelli, Antonio, and Elena tremoli
- Subjects
- *
OXIDATIVE stress , *COAGULATION - Published
- 2018
- Full Text
- View/download PDF
31. Neonatal intensive care parent satisfaction: a multicenter study translating and validating the Italian EMPATHIC-N questionnaire.
- Author
-
Dall’Oglio, Immacolata, Fiori, Martina, Tiozzo, Emanuela, Mascolo, Rachele, Portanova, Anna, Gawronski, Orsola, Ragni, Angela, Amadio, Patrizia, Cocchieri, Antonello, Fida, Roberta, Alvaro, Rosaria, Rocco, Gennaro, Latour, Jos M., and Italian Empathic-N Study Group
- Subjects
- *
STATISTICAL correlation , *CULTURE , *FACTOR analysis , *FAMILY medicine , *MEDICAL cooperation , *NEONATAL intensive care , *PSYCHOMETRICS , *QUESTIONNAIRES , *RESEARCH , *SATISFACTION , *NEONATAL intensive care units , *PARENT attitudes , *RESEARCH methodology evaluation , *FAMILY attitudes ,RESEARCH evaluation - Abstract
Background: In Neonatal Intensive Care Units (NICUs), parent satisfaction and their experiences are fundamental to assess clinical practice and improve the quality of care delivered to infants and parents. Recently, a specific instrument, the EMpowerment of PArents in THe Intensive Care-Neonatology (EMPATHIC-N), has been developed in the Netherlands. This instrument investigated different domains of care in NICUs from a family-centered care perspective. In Italy, no rigorous instruments are available to evaluate parent satisfaction and experiences in NICU with family-centered care. The aim of this study was to translate and validate the EMPATHIC-N instrument into Italian language measuring parent satisfaction. Methods: A psychometric study was conducted in nine Italian NICUs. The hospitals were allocated across Italy: four in the North, four in Central region, one in the South. Parents whose infants were discharged from the Units were enrolled. Parents whose infants died were excluded. Results: Back-forward translation was conducted. Twelve parents reviewed the instrument to assess the cultural adaptation; none of the items fell below the cut-off of 80% agreement. A total of 186 parents of infants who were discharged from nine NICUs were invited to participate and 162 parents responded and returned the questionnaire (87%). The mean scores of the individual items varied between 4.3 and 5.9. Confirmatory factor analysis was performed and all factor loadings were statistically significant with the exception of item ‘Our cultural background was taken into account’. The items related to overall satisfaction showed a higher trend with mean values of 5.8 and 5.9. The Cronbach’s alpha’s (at domain level 0.73-0.92) and corrected item-total scale correlations revealed high reliability estimates. Conclusions: The Italian EMPATHIC-N showed to be a valid and reliable instrument measuring parent satisfaction in NICUs from a family-centered care perspective. Indeed, it had good psychometric properties, validity, and reliability. Furthermore, this instrument is fundamental for further research and internationally benchmarking. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.